Sign up to save your podcasts
Or
Share Slashing US drug prices would come at a cost
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Slashing US drug prices would come at a cost
In many cases, the market charges nearly triple what others do, a discrepancy that has put President Trump on the warpath. In this Viewsroom podcast, Breakingviews columnists discuss how Americans subsidize novel treatments and how tricky it will be to spread the burden.
Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Reuters
4.2
4545 ratings
In many cases, the market charges nearly triple what others do, a discrepancy that has put President Trump on the warpath. In this Viewsroom podcast, Breakingviews columnists discuss how Americans subsidize novel treatments and how tricky it will be to spread the burden.
Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Viewsroom
View all
NPR News Now
14,381 Listeners
Marketplace Morning Report
924 Listeners
WSJ Your Money Briefing
1,721 Listeners
Bloomberg Intelligence
408 Listeners
Bloomberg Businessweek
431 Listeners
Trumponomics
355 Listeners
WSJ Tech News Briefing
1,637 Listeners
The Big View
28 Listeners
Up First from NPR
56,472 Listeners
Bold Names
1,451 Listeners
Consider This from NPR
6,389 Listeners
The Big Take
157 Listeners
Reuters World News
271 Listeners
WSJ's Take On the Week
146 Listeners
Reuters Econ World
27 Listeners